Alseres Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals

ALSE 0.00500

0.0%

Oct 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SR/WA who wrote (17)	6/25/1996 11:20:00 PM
From: Jack L. Dlugach	of 975

Ken: This just came across the Dow Newswire...it sounds pretty good for the company... WALTHAM,MASS--Boston Life Sciences obtained a worldwide exclusive rights to a patent application concerning a recently discovered transcription factor that has been shown, in preclinical in vitro test, to regulate the switching of T helper cells...this may be of significant value in the treatment of autoimmune diseases and allergies. The transcription factor...was discovered by a team of scientists...at Harvard...The company...expects to make development of products resulting from (this) discover...a major area of focus for the company...BLSI develops novel treatments for cancer, autoimmune diseases, and central nervous system disorders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next